Liquid and Hydrogel Phases of PrPC Linked to Conformation Shifts and Triggered by Alzheimer’s Amyloid-β Oligomers
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
SUMMARY Protein phase separation by low complexity, intrinsically disordered domains generates membraneless organelles and links to neurodegeneration. Cellular prion protein (PrPC) contains such domains, causes spongiform degeneration and is a receptor for Alzheimer’s amyloid-β oligomers (Aβo). Here, we show that PrPC separates as a liquid phase, in which α-helical Thr become unfolded. At the cell surface, PrPC Lys residues interact with Aβo to create a hydrogel containing immobile Aβo and relatively mobile PrPC. The Aβo/PrP hydrogel has a well-defined stoichiometry, and dissociates with excess Aβo. NMR studies of hydrogel PrPC reveal a distinct α-helical conformation for natively unfolded amino-terminal Gly and Ala residues. Aβo/PrP hydrogel traps signal-transducing mGluR5 on the plasma membrane. Recombinant PrPC extracts endogenous Aβo from human Alzheimer’s soluble brain lysates into hydrogel, and a PrPC antagonist releases Aßo from endogenous brain hydr ogel. Thus, coupled phase and conformational transitions of PrPC are driven by Aβ species from Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“Disease-specific Aβo are triggers for synaptic dysfunction, dendritic spine loss, inflammatory recruitment and memory dysfunction, as well as Tauopathy and cell loss (Hong et al., 2016; Lambert et al., 1998; Lesne et al., 2006; Selkoe and Hardy, 2016; Shankar et al., 2008).”
BackgroundRetractedThe amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“Disease-specific Aβo are triggers for synaptic dysfunction, dendritic spine loss, inflammatory recruitment and memory dysfunction, as well as Tauopathy and cell loss (Hong et al., 2016; Lambert et al., 1998; Lesne et al., 2006; Selkoe and Hardy, 2016; Shankar et al., 2008).”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 1×
“Disease-specific Aβo are triggers for synaptic dysfunction, dendritic spine loss, inflammatory recruitment and memory dysfunction, as well as Tauopathy and cell loss (Hong et al., 2016; Lambert et al., 1998; Lesne et al., 2006; Selkoe and Hardy, 2016; Shankar et al., 2008).”
BackgroundComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 1×
“Disease-specific Aβo are triggers for synaptic dysfunction, dendritic spine loss, inflammatory recruitment and memory dysfunction, as well as Tauopathy and cell loss (Hong et al., 2016; Lambert et al., 1998; Lesne et al., 2006; Selkoe and Hardy, 2016; Shankar et al., 2008).”
BackgroundLiquid-Liquid Phase Separation in Biology
Hyman, A. A., Weber, C. A., & Jülicher, F. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013325 · Cited by 3,155 · cited 1×
“Intrinsically disordered regions (IDRs) and low complexity domains (LCDs) can drive phase separation with formation of membraneless organelles (Chong and Forman-Kay, 2016; Hyman et al., 2014).”
BackgroundCellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560 · cited 6×
“Each PrPC molecule contains 2 Aβo binding sites at AA23–51 and AA91– 111 (Chen et al., 2010; Lauren et al., 2009).”
BackgroundInfluentialSelf-citationShapovalov, M. V., & Dunbrack, R. L. (2011) · Structure · doi:10.1016/j.str.2011.03.019 · Cited by 1,000
Ambadipudi, S., Biernat, J., Riedel, D., Mandelkow, E., & Zweckstetter, M. (2017) · Nature Communications · doi:10.1038/s41467-017-00480-0 · Cited by 782 · cited 1×
“Prominent amongst LLPS proteins are those implicated in neurodegeneration (Ambadipudi et al., 2017; Mackenzie et al., 2017; Molliex et al., 2015; Murray et al., 2017; Patel et al., 2015).”
BackgroundUm, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Self-citationBarghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559
Biology and Genetics of Prions Causing Neurodegeneration
Prusiner, S. B. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155524 · Cited by 455 · cited 2×
“Thus, initial steps in TSE and AD may trigger similar toxicity, and mGluR5 is implicated in PrPSc toxicity (Goniotaki et al., 2017).”
BackgroundMemory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., & Strittmatter, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0395-10.2010 · Cited by 418
Self-citationKostylev, M. A., Kaufman, A. C., Nygaard, H. B., Patel, P., Haas, L. T., Gunther, E. C., Vortmeyer, A., & Strittmatter, S. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.643577 · Cited by 133 · cited 7×
“PrPC Plate-Based binding assays—The assay principle and experimental protocol have been published (Kostylev et al., 2015; Um et al., 2012).”
BackgroundMethodInfluentialSelf-citation
Cited by
Franjic, D., Skarica, M., Ma, S., Arellano, J. I., Tebbenkamp, A. T. N., Choi, J., Xu, C., Li, Q., Morozov, Y. M., Andrijevic, D., et al. (2022) · Neuron · doi:10.1016/j.neuron.2021.10.036 · Cited by 308
“The collection and characteristics of the AD and neurologically intact control brain samples has been described previously (Kostylev et al., 2015; Kostylev et al., 2018).”
Self-citationLiquid–Liquid Phase Separation and Its Mechanistic Role in Pathological Protein Aggregation
Babinchak, W. M., & Surewicz, W. K. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.03.004 · Cited by 287
LLPSDB: a database of proteins undergoing liquid–liquid phase separation in vitro
Li, Q., Peng, X., Li, Y., Tang, W., Zhu, J., Huang, J., Qi, Y., & Zhang, Z. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz778 · Cited by 203
Spurrier, J., Nicholson, L., Fang, X. T., Stoner, A. J., Toyonaga, T., Holden, D., Siegert, T. R., Laird, W., Allnutt, M. A., Chiasseu, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abi8593 · Cited by 114
Self-citation(2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.08.002 · Cited by 78
Metadata
- Authors
- Kostylev, M. A., Tuttle, M. D., Lee, S., Klein, L. E., Takahashi, H., Cox, T. O., Gunther, E. C., Zilm, K. W., & Strittmatter, S. M.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 72
- Issue
- 3
- Pages
- 426-443.e12
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2898416998
- Cited by
- 106
- References
- 14
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.